Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 11.7B 982B P/E ratio 2025 *
61.4x
P/E ratio 2026 * 47.8x
Enterprise value 11.46B 962B EV / Sales 2025 *
9.53x
EV / Sales 2026 * 8.49x
Free-Float
99.01%
Yield 2025 *
0.43%
Yield 2026 * 0.45%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.34%
1 week+2.86%
Current month-0.28%
1 month+2.80%
3 months-4.31%
6 months-4.29%
Current year-4.38%
More quotes
1 week
70.81
Extreme 70.81
74.16
1 month
70.25
Extreme 70.25
75.60
Current year
61.16
Extreme 61.16
85.57
1 year
51.79
Extreme 51.79
85.57
3 years
51.79
Extreme 51.79
135.96
5 years
38.79
Extreme 38.7925
135.96
10 years
19.99
Extreme 19.9875
135.96
More quotes
Director TitleAgeSince
Chief Executive Officer 57 30/18/30
Director of Finance/CFO 53 01/14/01
Investor Relations Contact - 01/19/01
Manager TitleAgeSince
Chairman 67 01/03/01
Director/Board Member 74 01/90/01
Director/Board Member 53 19/09/19
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.34%+2.86%+2.73%-42.89%11.7B
-0.38%+0.89%+11.82%-28.49%46.68B
-2.35%-5.47%+10.15%-9.71%42.88B
+1.20%+0.96%+27.20%+35.17%32.89B
+3.49%+8.69%-26.35%-82.36%30.47B
+1.93%-0.61%+32.75%-22.35%30.1B
-6.10%-10.17%+12.13%+8.37%23.23B
-1.79%-2.82%+52.12%+62.87%15.24B
+0.02%+3.66%+7.10%-19.68%10.2B
-3.41%-6.32%+20.91%+70.99%10.14B
Average -0.92%-0.49%+15.06%-2.81% 25.35B
Weighted average by Cap. -0.84%-0.33%+13.63%-10.26%
See all sector performances
2025 *2026 *
Net sales 1.22B 102B 1.34B 112B
Net income 203M 17B 261M 21.94B
Net Debt -110M -9.23B -348M -29.24B
More financial data * Estimated data
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (74.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (25.7%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. Net sales are distributed geographically as follows: the United States (56.5%), the United Kingdom (4.4%), Europe/Middle East/Africa (19.4%), China (10%), Asia/Pacific (6.4%), and other (3.3%).
Employees
3,100
Related indices
More about the company
Date Price Change Volume
10/24/10 73.78 $ +2.34% 954,925
09/24/09 72.09 $ +0.84% 789,694
06/24/06 71.49 $ -1.22% 734,814
05/24/05 72.37 $ +1.76% 742,955
04/24/04 71.12 $ -0.85% 625,246

Delayed Quote Nasdaq, September 11, 2024 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
73.78USD
Average target price
82.55USD
Spread / Average Target
+11.89%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW